13.07.2021 13:39:16

AngioDynamics Guides FY22 Adj. EPS Below Estimates - Quick Facts

(RTTNews) - While reporting financial results for the fourth quarter on Tuesday, medical devices company AngioDynamics, Inc. (ANGO) initiated its adjusted earnings and net sales guidance for the full year 2022.

For fiscal 2022, the company now projects adjusted earnings in a range of flat to $0.05 per share on net sales between $305 million and $310 million.

On average, three analysts polled by Thomson Reuters expect the company to report earnings of $0.07 per share on net sales of $297.9 million for the year. Analysts' estimates typically exclude special items.

Analysen zu AngioDynamics Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

AngioDynamics Inc. 8,70 0,58% AngioDynamics Inc.